DOI: 10.1128/AAC.00330-16
Article Information
PubMed
Published By
History
- Received February 10, 2016
- Returned for modification March 11, 2016
- Accepted May 19, 2016
- Published online July 22, 2016.
Copyright & Usage
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (May 23, 2016).
- You are viewing the most recent version of this article.
Author Information
- Stefano Cristallinia,
- Maya Hitesb,
- Hakim Kabtouria,
- Jason A. Robertsc,d,
- Marjorie Beumiera,
- Frederic Cottone,
- Jeffrey Lipmanc,
- Frédérique Jacobsb,
- Jean-Louis Vincenta,
- Jacques Creteura and
- Fabio Silvio Tacconea
- aDepartment of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- bDepartment of Infectious Diseases, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- cBurns, Trauma and Critical Care Research Centre, The University of Queensland, Herston, Queensland, Australia
- dSchool of Pharmacy, The University of Queensland, Herston, Queensland, Australia
- eDepartment of Clinical Chemistry, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- Address correspondence to Fabio Silvio Taccone, ftaccone{at}ulb.ac.be.
S.C. and M.H. contributed equally to this article.
Citation Cristallini S, Hites M, Kabtouri H, Roberts JA, Beumier M, Cotton F, Lipman J, Jacobs F, Vincent J-L, Creteur J, Taccone FS. 2016. New regimen for continuous infusion of vancomycin in critically ill patients. Antimicrob Agents Chemother 60:4750–4756. doi:10.1128/AAC.00330-16.
